Author Archive

Senate Passes 2023 Omnibus Appropriations Bill

https://www.appropriations.senate.gov/imo/media/doc/Division%20H%20-%20LHHS%20Statement%20FY23.pdf

Senate Passes 2023 Omnibus Appropriations Bill

Below Article Update 12/23/2022: Following Senate passage by a 68-29 vote on Thursday, Dec. 22, the House passed an omnibus appropriations bill by a 221-205-1 vote on Friday, Dec. 23.  The President is expected to sign the measure.  To allow more time for full enactment of the omnibus, Congress passed a third continuing resolution for FY 2023 through Dec. 30, which the President signed on Friday, Dec. 23. 

Alert: Senate Releases 2023 Omnibus Appropriations Bill:  The Senate has just released the 2023 Omnibus Appropriations Bill.2023 Omnibus Appropriations Bill The Explanatory Statement includes, under Emerging & Zoonotic Infectious Diseases, $26M for Lyme, as well as much language on Lyme/VBD. It also incorporates activities in HR117-403 which includes Lyme language LDA provided to Congress.

The passage of an Omnibus through the end of FY23 is uncertain at this time.

**Comment**

Don’t expect much, if anything, to come of this.  Just more money going into the hands of The Cabal to do more of the same – line their pockets at the expense of sick patients. 

Category:

Activism, Lyme

Another Win for Early Ivermectin Treatment: It Blocks Hemagglutination

**UPDATE**

Go here to learn of all the things ivermectin does, where to get it, and treatment protocols.

https://palexander.substack.com/p/another-win-for-early-treatment-ivermectin?

Another win for early treatment Ivermectin (IVM), it blocks hemagglutination: “SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for

Vaccine Adverse Effects”; Boschi et al. “IVM blocked HA when added to RBCs prior to spike protein and reversed HA when added afterward.”

Dr. Paul Alexander

Ijms 23 15480 g001 550

SOURCE:

https://www.mdpi.com/1422-0067/23/24/15480

Abstract

Experimental findings for SARS-CoV-2 related to the glycan biochemistry of coronaviruses indicate that attachments from spike protein to glycoconjugates on the surfaces of red blood cells (RBCs), other blood cells and endothelial cells are key to the infectivity and morbidity of COVID-19. To provide further insight into these glycan attachments and their potential clinical relevance, the classic hemagglutination (HA) assay was applied using spike protein from the Wuhan, Alpha, Delta and Omicron B.1.1.529 lineages of SARS-CoV-2 mixed with human RBCs. The electrostatic potential of the central region of spike protein from these four lineages was studied through molecular modeling simulations. Inhibition of spike protein-induced HA was tested using the macrocyclic lactone ivermectin (IVM), which is indicated to bind strongly to SARS-CoV-2 spike protein glycan sites. The results of these experiments were, first, that spike protein from these four lineages of SARS-CoV-2 induced HA. Omicron induced HA at a significantly lower threshold concentration of spike protein than the three prior lineages and was much more electropositive on its central spike protein region. IVM blocked HA when added to RBCs prior to spike protein and reversed HA when added afterward. These results validate and extend prior findings on the role of glycan bindings of viral spike protein in COVID-19. They furthermore suggest therapeutic options using competitive glycan-binding agents such as IVM and may help elucidate rare serious adverse effects (AEs) associated with COVID-19 mRNA vaccines, which use spike protein as the generated antigen.

(See link for article)

_________________

**Comment**

This study, which should prove the effectiveness of IVM on the spike protein, either from infection or from “vaccination,” also shows why “the powers that be” are so desperate to malign it, and hide it under the rug, despite states and courts ordering it.

Ivermectin, BTW is what many doctors are using with their COVID “vaccine” injured patients.  Incidentally, one of the authors of this study, Jacque Fantini, was the senior scientist whose team found that ADE was happening at the beginning of the mass COVID “vaccination” program which pushed Delta through Europe and only caused the virus to mutate.

For more:

Category:

Activism, research, Treatment, Viruses

PIC Updates ‘Aluminum – Vaccine Risk Statement’ to Include Association Between Aluminum & Asthma

https://physiciansforinformedconsent.org/pic-updates-its-aluminum-vaccine-risk-statement-document-includes-data-on-association-between-aluminum-in-vaccines-and-childhood-asthma/

PIC Updates Its ‘Aluminum – Vaccine Risk Statement’: Document Includes Data on Association Between Aluminum in Vaccines and Childhood Asthma

Physicians for Informed Consent (PIC) Updates Its ‘Aluminum – Vaccine Risk Statement’: Document Includes Data on Association Between Aluminum in Vaccines and Childhood Asthma

According to PIC, adverse effects of aluminum may not be restricted to neurological conditions*

NEWPORT BEACH, Calif., December 29, 2022 (Newswire.com) – Physicians for Informed Consent (PIC) has released an update to its Aluminum  – Vaccine Risk Statement (VRS) titled “Aluminum in Vaccines: What Parents Need to Know.” The concise, two-page educational document — which serves to answer important questions about the risks of aluminum-containing vaccines — now includes important data about a study’s link between aluminum in vaccines and asthma. Asthma is a disease that affects the lungs. It causes repeated episodes of wheezing, breathlessness, chest tightness, and nighttime or early morning coughing.

Developed from data compiled by the Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), and the Agency for Toxic Substances and Disease Registry (ATSDR), the PIC document provides reader-friendly Q&As on topics such as:

  • Why is aluminum in vaccines?
  • Which vaccines contain aluminum?
  • How much aluminum is in vaccines?
  • Is exposure to aluminum from vaccines safe?

The document explains that both the FDA and ATSDR have raised concerns about the negative effects of aluminum exposure in humans. Scientific studies have shown that small amounts of aluminum can interfere with cellular and metabolic processes in the nervous system. Some of the most damaging effects of aluminum range from motor skill impairment to encephalopathy (altered mental state, personality changes, difficulty thinking, loss of memory, seizures, coma, and more).

Studies have also shown that adverse effects of aluminum may not be restricted to neurological conditions.* A study referenced in the PIC document and published in Academic Pediatrics found that asthma occurred in 1 in 183 vaccinated children for every 1 mg (1,000 mcg) increase in aluminum exposure. In the United States, up to 22 doses of aluminum-containing vaccines are administered to children, with 11 doses administered from birth to 6 months of age.

“Overexposure to aluminum may lead to significant harm,” said Dr. Shira Miller, founder and president of Physicians for Informed Consent. “In California, where PIC is headquartered, since Senate Bill 277 (SB 277) was enacted in 2015, numerous doses of aluminum-containing vaccines are mandated for public and private K-12 school attendance — with no exceptions for religious or personal belief exemptions. PIC asserts that vaccine mandates are unscientific and unethical and a threat to public health. SB 277, and any other law that coerces vaccination, needs to be repealed.”

To read or download the educational document “Aluminum in Vaccines: What Parents Need to Know,” please visit physiciansforinformedconsent.org/aluminum.

* In 2008, the Agency for Toxic Substances and Disease Registry (ATSDR), a division of HHS, used studies of the neurotoxic effects of aluminum to determine that no more than 1 milligram (mg) (1,000 micrograms [mcg]) of aluminum per kilogram (kg) of body weight should be taken orally per day to avoid aluminum’s negative effects.

Physicians for Informed Consent is a 501(c)(3) nonprofit educational organization focused on science and statistics. PIC delivers data on infectious diseases and vaccines, and unites doctors, scientists, healthcare professionals, attorneys, and families who support voluntary vaccination. In addition, the PIC Coalition for Informed Consent consists of over 300 U.S. and international organizations. Click here to make a donation.

Press Contact:
info@picphysicians.org
925-642-6651

CLICK HERE to view on Newswire.
CLICK HERE to share on Twitter.
CLICK HERE to share on Facebook.
CLICK HERE to share on Instagram.
CLICK HERE to share on LinkedIn.

_______________
For more:

Category:

Activism, vaccines

Genomic Confirmation of Borrelia garinii, United States

https://wwwnc.cdc.gov/eid/article/29/1/22-0930_article

Volume 29, Number 1—January 2023
Natalie RudenkoComments to Author , Maryna Golovchenko, Ales Horak, Libor Grubhoffer, Emmanuel F. Mongodin1, Claire M. Fraser, Weigang Qiu, Benjamin J. Luft, Richard G. Morgan, Sherwood R. Casjens, and Steven E. Schutzer
 
 

Abstract

Lyme disease is a multisystem disorder primarily caused by Borrelia burgdorferi sensu lato. However, B. garinii, which has been identified on islands off the coast of Newfoundland and Labrador, Canada, is a cause of Lyme disease in Eurasia. We report isolation and whole-genome nucleotide sequencing of a B. garinii isolate from a cotton mouse (Peromyscus gossypinus) in South Carolina, USA. We identified a second B. garinii isolate from the same repository. Phylogenetic analysis does not associate these isolates with the previously described isolates of B. garinii from Canada.

_________________

Important excerpt:

How and when B. garinii arrived in South Carolina remains unknown. There were no reported Lyme disease outbreaks in the southeastern United States in humans at the time the strains were deposited in the repository or during the subsequent 2 decades. This finding minimizes the urgency for an immediate new search for B. garinii in this region. Nonetheless, clinical vigilance for B. garinii in humans in this region seems warranted.

 

True to form, the CDC downplays the finding of a new strain which very well could explain why sick patients continue to be mis or undiagnosed due to faulty testing and strain diversity, which will never be picked up using current 2-tiered CDC testing because it doesn’t look for other strains.

But, truth be damned.  It just doesn’t matter to corrupt public health.

Category:

Lyme, research, Testing, Ticks

3 Reasons Lyme/MSIDS Patients Remain Sick: Dormancy/Persisters, Biofilm, Co-Infection

https://parasitesandvectors.biomedcentral.com/articles/10.1186/s13071-019-3495-7

Metamorphoses of Lyme disease spirochetes: phenomenon of Borrelia persisters

Parasites & Vectors volume 12, Article number: 237 (2019) Cite this article

Abstract

The survival of spirochetes from the Borrelia burgdorferi (sensu lato) complex in a hostile environment is achieved by the regulation of differential gene expression in response to changes in temperature, salts, nutrient content, acidity fluctuation, multiple host or vector dependent factors, and leads to the formation of dormant subpopulations of cells. From the other side, alterations in the level of gene expression in response to antibiotic pressure leads to the establishment of a persisters subpopulation. Both subpopulations represent the cells in different physiological states. “Dormancy” and “persistence” do share some similarities, e.g. both represent cells with low metabolic activity that can exist for extended periods without replication, both constitute populations with different gene expression profiles and both differ significantly from replicating forms of spirochetes. Persisters are elusive, present in low numbers, morphologically heterogeneous, multi-drug-tolerant cells that can change with the environment. The definition of “persisters” substituted the originally-used term “survivors”, referring to the small bacterial population of Staphylococcus that survived killing by penicillin. The phenomenon of persisters is present in almost all bacterial species; however, the reasons why Borrelia persisters form are poorly understood. Persisters can adopt varying sizes and shapes, changing from well-known forms to altered morphologies. They are capable of forming round bodies, L-form bacteria, microcolonies or biofilms-like aggregates, which remarkably change the response of Borrelia to hostile environments. Persisters remain viable despite aggressive antibiotic challenge and are able to reversibly convert into motile forms in a favorable growth environment. Persisters are present in significant numbers in biofilms, which has led to the explanation of biofilm tolerance to antibiotics. Considering that biofilms are associated with numerous chronic diseases through their resilient presence in the human body, it is not surprising that interest in persisting cells has consequently accelerated. Certain diseases caused by pathogenic bacteria (e.g. tuberculosis, syphilis or leprosy) are commonly chronic in nature and often recur despite antibiotic treatment. Three decades of basic and clinical research have not yet provided a definite answer to the question: is there a connection between persisting spirochetes and recurrence of Lyme disease in patients?

______________

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287027/

The Emerging Role of Microbial Biofilm in Lyme Neuroborreliosis

Enea Gino Di Domenico,1,* Ilaria Cavallo,1 Valentina Bordignon,1 Giovanna D’Agosto,1 Martina Pontone,1 Elisabetta Trento,1 Maria Teresa Gallo,1 Grazia Prignano,1 Fulvia Pimpinelli,1 Luigi Toma,2 and Fabrizio Ensoli1
Author information Article notes Copyright and License information Disclaimer
 

Abstract

Lyme borreliosis (LB) is the most common tick-borne disease caused by the spirochete Borrelia burgdorferi in North America and Borrelia afzelii or Borrelia garinii in Europe and Asia, respectively. The infection affects multiple organ systems, including the skin, joints, and the nervous system. Lyme neuroborreliosis (LNB) is the most dangerous manifestation of Lyme disease, occurring in 10–15% of infected individuals. During the course of the infection, bacteria migrate through the host tissues altering the coagulation and fibrinolysis pathways and the immune response, reaching the central nervous system (CNS) within 2 weeks after the bite of an infected tick. The early treatment with oral antimicrobials is effective in the majority of patients with LNB. Nevertheless, persistent forms of LNB are relatively common, despite targeted antibiotic therapy. It has been observed that the antibiotic resistance and the reoccurrence of Lyme disease are associated with biofilm-like aggregates in B. burgdorferi, B. afzelii, and B. garinii, both in vitro and in vivo, allowing Borrelia spp. to resist to adverse environmental conditions. Indeed, the increased tolerance to antibiotics described in the persisting forms of Borrelia spp., is strongly reminiscent of biofilm growing bacteria, suggesting a possible role of biofilm aggregates in the development of the different manifestations of Lyme disease including LNB.

________________

https://www.fortunejournals.com/articles/serological-and-pcr-evidence-of-infection-in-105-patients-with-sppt.html

Serological and PCR evidence of Infection in 105 Patients with SPPT

Alexis Lacout1*, Marie Mas4, Michel Franck2, Véronique Perronne3, Julie Pajaud2, Pierre Yves Marcy5, Christian Perronne3

*Corresponding Author: Alexis Lacout, Centre de diagnostic ELSAN, Centre Médico–Chirurgical, 83 avenue Charles de Gaulle, 15000, Aurillac, France

Received: 11 December 2020; Accepted: 22 December 2020; Published: 05 January 2021

Citation: Alexis Lacout, Marie Mas, Michel Franck, Véronique Perronne, Julie Pajaud, Pierre Yves Marcy, Christian Perronne. Serological and PCR evidence of Infection in 105 Patients with SPPT. Archives of Microbiology & Immunology 5 (2021): 139-150.

Abstract

Introduction: The main aim of this study is to determine the nature of the exposure of patients presenting with polymorphic signs and symptoms to the parasite Babesia, through the study of serology. The secondary aim is to report the different serological or PCR results observed in these patients.

Material and methods: The following serologies were performed in all patients looking for: Babesia divergens, Borrelia, Bartonella, Coxiella burnetii, Anaplasma phagocytophilum. The following PCRs were performed looking for: Borrelia spp, Babesia spp, Bartonella (Bartonella spp, B. quintana, B. Henselae,) Coxiella spp, Anaplasma spp, Ehrlichia spp, Rickettsia spp, most often on several matrices (venous blood, capillary blood, urine and saliva).

Results: In this study, 105 patients were included, 62 females and 43 males, sex ratio F/M was 62/43 = 1.44; mean age was 45.5 year old (range; 5 years, 79 years old).

  • Of the 105 serologies for B. divergens, 41% were found to be positive.
  • Of the 104 serologies for Borrelia, 19.2% were found to be positive.
  • Of the 95 serologies for Anaplasma, 27.3% were found to be positive.

Borrelia spp, Babesia spp, Bartonella spp, Coxiella spp, Anaplasma spp, Ehrlichia spp, Rickettsia spp were found by using rtPCR.

Conclusion: Our study has shown that patients with SPPT/PTLDS, a syndrome close to fibromyalgia, could harbor several tick borne microorganisms. Microbiologic analyses should thus not be merely limited to Borrelia’s research alone.

______________

**Comment**

These relatively recent studies (within the past few years) reveal what Lyme literate doctors and their patients have been experiencing from the beginning.  They also reaffirm what many independent researchers have globally been writing about for years.  There are many other reasons patients remain ill as well but these three are biggies.

Yet, reality is best summed up by the following quote from the first study listed above:

Three decades of basic and clinical research have not yet provided a definite answer to the question: is there a connection between persisting spirochetes and recurrence of Lyme disease in patients?

Isn’t that sad?

The same, of course, can be said of biofilm and coinfections as well. Decades have gone by with no definitive answers because The Cabal doesn’t want the truth to be known. Why? Quite simple: a chronic, relapsing illness doesn’t fit their “vaccine” narrative which is the favored golden calf and cash cow of research institutions and our government, which have a cozy relationship with Big Pharma and Big Media.  This is quite convenient for all of them as they control all the messaging as well as threaten, censor, and ban doctors who dissent.

This has been blatantly exposed during the time of COVID but is nothing new.  Lymeland has been riddled with the exact same issues for 40 years.  Unfortunately, even well-meaning advocates and patients evidently can not see this and continue to demand more money and become giddy when they get it from the very agencies behind this debacle, who are incidentally profiting from it.

It’s a hot-mess for sure, but one thing is certain: we must stop playing into their hands by being ignorant or filled with “hopium,” a term I use to describe how hope can become a drug that stops you from thinking critically, logically, and honestly.

For more:

Category:

Anaplasmosis, Babesia, Bartonella, Biofilm, Ehrlichiosis, Lyme, research, Rickettsia, Testing